皓元医药: 关于上海皓元医药股份有限公司非经营性资金占用及其他关联资金往来情况汇总表的专项审计报告

Summary of Shanghai Haoyuan Pharmaceutical Co., Ltd. - The report focuses on the non-operating fund occupation and other related fund transactions of Shanghai Haoyuan Pharmaceutical Co., Ltd. [1] - The audit was conducted by Rongcheng Accounting Firm (Special General Partnership) [1] Non-operating Fund Occupation - The total amount of non-operating fund occupation at the beginning of 2024 was not disclosed, with the cumulative amount for the year also not specified [1] - The report indicates that there are no non-operating fund occupations from the actual controlling shareholders and their subsidiaries [1] - The total amount of non-operating fund occupation at the end of 2024 is also not provided [1] Related Fund Transactions - The report lists various related fund transactions with specific amounts, including: - Shanghai Haohong Biological Technology Co., Ltd. had a transaction amount of 441,991,091.80 [2] - Anhui Haoyuan Pharmaceutical Co., Ltd. had a transaction amount of 62,000,992.36 [2] - Other subsidiaries also reported various amounts, such as 25,362,210.21 from Heze Haoyuan Pharmaceutical Technology Co., Ltd. [2] - The total amount of related fund transactions at the end of 2024 was reported as 801,505,992.80 [3]